|
1
|
Esteller M: DNA methylation and cancer
therapy: New developments and expectations. Curr Opin Oncol.
17:55–60. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lewandowska J and Bartoszek A: DNA
methylation in cancer development, diagnosis and therapy - multiple
opportunities for genotoxic agents to act as methylome disruptors
or remediators. Mutagenesis. 26:475–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xia Y, Zhang M, Zhang X and Liu X: A
systematic review and meta-analysis of runt-related transcription
factor 3 gene promoter hypermethylation and risk of gastric cancer.
J Cancer Res Ther. 10:(Suppl). 310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pellacani D, Kestoras D, Droop AP, Frame
FM, Berry PA, Lawrence MG, Stower MJ, Simms MS, Mann VM, Collins
AT, et al: DNA hypermethylation in prostate cancer is a consequence
of aberrant epithelial differentiation and hyperproliferation. Cell
Death Differ. 21:761–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wojdacz TK, Windeløv JA, Thestrup BB,
Damsgaard TE, Overgaard J and Hansen L: Identification and
characterization of locus-specific methylation patterns within
novel loci undergoing hypermethylation during breast cancer
pathogenesis. Breast Cancer Res. 16:R172014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedrich MJ, Rad R, Langer R, et al: Lack
of RUNX3 regulation in human gastric cancer. J Pathol. 210:141–146.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen LF: Tumor suppressor function of
RUNX3 in breast cancer. J Cell Biochem. 113:1470–1477.
2012.PubMed/NCBI
|
|
8
|
Lee CW, Chuang LS, Kimura S, et al: RUNX3
functions as an oncogene in ovarian cancer. Gynecol Oncol.
122:410–417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsunematsu T, Kudo Y, Iizuka S, et al:
RUNX3 has an oncogenic role in head and neck cancer. PloS One.
4:e58922009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Tan SY, Zhang J and You HX: Effects
of paeonol on intracellular calcium concentration and expression of
RUNX3 in LoVo human colon cancer cells. Mol Med Rep. 7:1425–1430.
2013.PubMed/NCBI
|
|
11
|
Slattery ML, Lundgreen A, Herrick JS, Caan
BJ, Potter JD and Wolff RK: Associations between genetic variation
in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and
rectal cancer: additional support for a TGF-β-signaling pathway.
Carcinogenesis. 32:318–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Issa JP: CpG island methylator phenotype
in cancer. Nat Rev Cancer. 4:988–993. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
15
|
Vogelmann R, Nguyen-Tat MD, Giehl K, Adler
G, Wedlich D and Menke A: TGFbeta-induced downregulation of
E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN.
J Cell Sci. 118:4901–4912. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subramaniam MM, Chan JY, Soong R, Ito K,
Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, et
al: RUNX3 inactivation in colorectal polyps arising through
different pathways of colonic carcinogenesis. Am J Gastroenterol.
104:426–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miyazono K, Maeda S and Imamura T:
Coordinate regulation of cell growth and differentiation by
TGF-beta superfamily and Runx proteins. Oncogene. 23:4232–4237.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soong R, Shah N, Peh BK, Chong PY, Ng SS,
Zeps N, Joseph D, Salto-Tellez M, Iacopetta B and Ito Y: The
expression of RUNX3 in colorectal cancer is associated with disease
stage and patient outcome. Br J Cancer. 100:676–679. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ku JL, Kang SB, Shin YK, Kang HC, Hong SH,
Kim IJ, Shin JH, Han IO and Park JG: Promoter hypermethylation
downregulates RUNX3 gene expression in colorectal cancer cell
lines. Oncogene. 23:6736–6742. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li QL, Ito K, Sakakura C, Fukamachi H,
Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al: Causal
relationship between the loss of RUNX3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park WS, Cho YG, Kim CJ, Song JH, Lee YS,
Kim SY, Nam SW, Lee SH, Yoo NJ and Lee JY: Hypermethylation of the
RUNX3 gene in hepatocellular carcinoma. Exp Mol Med. 37:276–281.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li
QL, Yang JO, Ito Y and Bae SC: RUNX3 inactivation by point
mutations and aberrant DNA methylation in bladder tumors. Cancer
Res. 65:9347–9354. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sato K, Tomizawa Y, Iijima H, Saito R,
Ishizuka T, Nakajima T and Mori M: Epigenetic inactivation of the
RUNX3 gene in lung cancer. Oncol Rep. 15:129–135. 2006.PubMed/NCBI
|
|
24
|
Hiramatsu T, Osaki M, Ito Y, Tanji Y,
Tokuyasu N and Ito H: Expression of RUNX3 protein in human
esophageal mucosa and squamous cell carcinoma. Pathobiology.
72:316–324. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vogiatzi P, De Falco G, Claudio PP and
Giordano A: How does the human RUNX3 gene induce apoptosis in
gastric cancer? Latest data, reflections and reactions. Cancer Biol
Ther. 5:371–374. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kato N, Tamura G, Fukase M, Shibuya H and
Motoyama T: Hypermethylation of the RUNX3 gene promoter in
testicular yolk sac tumor of infants. Am J Pathol. 163:387–391.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen W, Salto-Tellez M, Palanisamy N,
Ganesan K, Hou Q, Tan LK, Sii LH, Ito K, Tan B, Wu J, et al:
Targets of genome copy number reduction in primary breast cancers
identified by integrative genomics. Genes Chromosomes Cancer.
46:288–301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goel A, Arnold CN, Tassone P, Chang DK,
Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ,
Bertagnolli MM, et al: Epigenetic inactivation of RUNX3 in
microsatellite unstable sporadic colon cancers. Int J Cancer.
112:754–759. 2004. View Article : Google Scholar : PubMed/NCBI
|
